Minden M - Search Results

1

Lübbert M, Minden M. Lübbert M, et al. Among authors: minden m. Semin Hematol. 2005 Jul;42(3 Suppl 2):S38-42. doi: 10.1053/j.seminhematol.2005.05.007. Semin Hematol. 2005. PMID: 16015504 Review.

2

Acute leukemia in adults.

Minden M, Imrie K, Keating A. Minden M, et al. Curr Opin Hematol. 1996 Jul;3(4):259-65. doi: 10.1097/00062752-199603040-00003. Curr Opin Hematol. 1996. PMID: 9372086 Review.

3

Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.

Gupta V, Chun K, Yi QL, Minden M, Schuh A, Wells R, Brandwein J. Gupta V, et al. Among authors: minden m. Cancer. 2005 May 15;103(10):2082-90. doi: 10.1002/cncr.21006. Cancer. 2005. PMID: 15830348 Free article.

4

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.

Brandwein JM, Gupta V, Schuh AC, Schimmer AD, Yee K, Xu W, Messner HA, Lipton JH, Minden MD. Brandwein JM, et al. Among authors: minden md. Am J Hematol. 2008 Jan;83(1):54-8. doi: 10.1002/ajh.21034. Am J Hematol. 2008. PMID: 17696207 Free article.

5

Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.

Saini L, Minden MD, Schuh AC, Yee KW, Schimmer AD, Gupta V, Atenafu EG, Murray C, Nixon S, Brandwein JM. Saini L, et al. Among authors: minden md. Am J Hematol. 2012 Mar;87(3):323-6. doi: 10.1002/ajh.22268. Epub 2011 Dec 27. Am J Hematol. 2012. PMID: 22213349 Free article.

6

Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.

Emadi A, Jun SA, Tsukamoto T, Fathi AT, Minden MD, Dang CV. Emadi A, et al. Exp Hematol. 2014 Apr;42(4):247-51. doi: 10.1016/j.exphem.2013.12.001. Epub 2013 Dec 11. Exp Hematol. 2014. PMID: 24333121 Free article.

7

Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia.

Gupta V, Minden MD, Yi QL, Brandwein J, Chun K. Gupta V, et al. Leuk Res. 2003 Nov;27(11):983-91. doi: 10.1016/s0145-2126(03)00076-6. Leuk Res. 2003. PMID: 12859991 Review.

8

Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.

Chang H, Salma F, Yi QL, Patterson B, Brien B, Minden MD. Chang H, et al. Leuk Res. 2004 Jan;28(1):43-8. doi: 10.1016/s0145-2126(03)00180-2. Leuk Res. 2004. PMID: 14630079

9

Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.

Gupta V, Daly A, Lipton JH, Hasegawa W, Chun K, Kamel-Reid S, Tsang R, Yi QL, Minden M, Messner H, Kiss T. Gupta V, et al. Among authors: minden m. Biol Blood Marrow Transplant. 2005 Oct;11(10):764-72. doi: 10.1016/j.bbmt.2005.06.006. Biol Blood Marrow Transplant. 2005. PMID: 16182177 Free article. Clinical Trial.

10

Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?

Aswald JM, Wang XH, Aswald S, Lutynski A, Minden MD, Messner HA, Keating A. Aswald JM, et al. Among authors: minden md. Cytometry B Clin Cytom. 2006 Nov 15;70(6):379-90. doi: 10.1002/cyto.b.20115. Cytometry B Clin Cytom. 2006. PMID: 16977635 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters